A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost constraints in the region’s publicly funded health care systems continue to hinder adoption of premium-priced DCBs and DES and limit the pace of revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Latin America from 2019 through 2032.